NASDAQ: EVOK
Evoke Pharma Inc Stock Ownership - Who owns Evoke Pharma?

Insider buying vs selling

Have Evoke Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Matthew J. DonofrioChief Executive Officer2025-03-211,000$2.80
$2.80kBuy
Mark KowieskiChief Financial Officer2025-03-204,500$3.21
$14.46kBuy
Matthew J. DonofrioChief Executive Officer2025-02-286,849$3.65
$25.00kBuy
Nantahala Capital Management LLC10% Owner2025-01-2841$4.39
$179.87Sell

1 of 1

EVOK insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EVOK insiders and whales buy or sell their stock.

EVOK Shareholders

What type of owners hold Evoke Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Lvp GP III LLC139.90%2,088,579$4.49MInsider
Kenneth J. Widder106.41%1,588,579$3.42MInsider
Brian H. Dovey76.27%1,138,583$2.45MInsider
Kathleen K. Schoemaker76.27%1,138,583$2.45MInsider
Nicole Vitullo76.27%1,138,583$2.45MInsider
James C. Blair76.27%1,138,583$2.45MInsider
Jesse I. Treu76.27%1,138,583$2.45MInsider
Brian K. Halak76.27%1,138,583$2.45MInsider
Domain Parters VII L P40.61%606,283$1.30MInsider
David A. Gonyer22.76%339,782$730.53kInsider

1 of 3

EVOK vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EVOK1.82%98.18%Net BuyingNet Buying
SBFM0.51%99.49%
SNOA0.52%99.48%
PRFX2.95%0.00%
SXTC0.27%0.00%

Evoke Pharma Stock Ownership FAQ

Who owns Evoke Pharma?

Evoke Pharma (NASDAQ: EVOK) is owned by 14.63% institutional shareholders, 788.36% Evoke Pharma insiders, and 0.00% retail investors. Lvp GP III LLC is the largest individual Evoke Pharma shareholder, owning 2.09M shares representing 139.90% of the company. Lvp GP III LLC's Evoke Pharma shares are currently valued at $4.86M.

If you're new to stock investing, here's how to buy Evoke Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.